Preclinical mouse models suggest that therapeutic interventions, such as the SCD1 inhibitor aramchol in combination with stearate-supplemented high-fat diet (S-HFD), reduce distant metastasis of CM, presenting a potential strategy for cancer management. Here, SCD is linked to cancer.